Anna Manzo

603 total citations
25 papers, 398 citations indexed

About

Anna Manzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anna Manzo has authored 25 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Anna Manzo's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Anna Manzo is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Anna Manzo collaborates with scholars based in Italy, France and Poland. Anna Manzo's co-authors include Alessandro Morabito, Agnese Montanino, Raffaele Costanzo, Guido Carillio, Claudia Sandomenico, Nicola Normanno, Maria Carmela Piccirillo, Vincenzo Sforza, Giovanna Esposito and Giuliano Palumbo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Anna Manzo

25 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Manzo Italy 10 248 170 164 82 73 25 398
Mariano Siguero Spain 11 198 0.8× 82 0.5× 136 0.8× 108 1.3× 64 0.9× 26 330
Priscilla Cascetta Italy 10 234 0.9× 135 0.8× 142 0.9× 57 0.7× 84 1.2× 15 368
Kate Young United Kingdom 11 240 1.0× 115 0.7× 92 0.6× 64 0.8× 45 0.6× 30 365
Monica Capozzi Italy 11 239 1.0× 72 0.4× 133 0.8× 122 1.5× 94 1.3× 22 434
Sakiko Otani Japan 13 465 1.9× 404 2.4× 142 0.9× 84 1.0× 92 1.3× 45 613
Tae‐You Kim South Korea 9 194 0.8× 121 0.7× 182 1.1× 37 0.5× 82 1.1× 10 402
Yalei Zhang China 10 167 0.7× 165 1.0× 160 1.0× 46 0.6× 75 1.0× 16 356
Brigida Stanzione Italy 9 218 0.9× 150 0.9× 163 1.0× 29 0.4× 132 1.8× 24 411
Ryo Ko Japan 12 299 1.2× 392 2.3× 122 0.7× 31 0.4× 87 1.2× 60 547
Dario Nicolella Italy 9 227 0.9× 158 0.9× 108 0.7× 28 0.3× 45 0.6× 16 332

Countries citing papers authored by Anna Manzo

Since Specialization
Citations

This map shows the geographic impact of Anna Manzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Manzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Manzo more than expected).

Fields of papers citing papers by Anna Manzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Manzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Manzo. The network helps show where Anna Manzo may publish in the future.

Co-authorship network of co-authors of Anna Manzo

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Manzo. A scholar is included among the top collaborators of Anna Manzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Manzo. Anna Manzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morabito, Alessandro, Edoardo Mercadante, Paolo Muto, et al.. (2024). Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working. SHILAP Revista de lepidopterología. 5(2). 260–277. 2 indexed citations
2.
Manzo, Anna, Vincenzo Sforza, Guido Carillio, et al.. (2022). Lurbinectedin in small cell lung cancer. Frontiers in Oncology. 12. 932105–932105. 15 indexed citations
3.
Morabito, Alessandro, Anna Manzo, Agnese Montanino, et al.. (2022). Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion. The Oncologist. 27(1). 7–12. 3 indexed citations
4.
Sforza, Vincenzo, Giuliano Palumbo, Priscilla Cascetta, et al.. (2022). BRAF Inhibitors in Non-Small Cell Lung Cancer. Cancers. 14(19). 4863–4863. 21 indexed citations
5.
Montanino, Agnese, Anna Manzo, Guido Carillio, et al.. (2021). Angiogenesis Inhibitors in Small Cell Lung Cancer. Frontiers in Oncology. 11. 655316–655316. 53 indexed citations
6.
Manzo, Anna, Guido Carillio, Agnese Montanino, et al.. (2020). The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer. Expert Opinion on Drug Safety. 19(7). 775–783. 1 indexed citations
7.
Palumbo, Giuliano, Giovanna Esposito, Guido Carillio, et al.. (2020). Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer. SHILAP Revista de lepidopterología. 1(2). 117–130. 1 indexed citations
8.
Esposito, Giovanna, Giuliano Palumbo, Guido Carillio, et al.. (2020). Immunotherapy in Small Cell Lung Cancer. Cancers. 12(9). 2522–2522. 72 indexed citations
9.
Palumbo, Giuliano, Guido Carillio, Anna Manzo, et al.. (2019). Pembrolizumab in Lung Cancer: Current Evidence and Future Perspectives. Future Oncology. 15(29). 3327–3336. 5 indexed citations
10.
11.
Manzo, Anna, Agnese Montanino, Guido Carillio, et al.. (2017). Angiogenesis Inhibitors in NSCLC. International Journal of Molecular Sciences. 18(10). 2021–2021. 78 indexed citations
12.
13.
Manzo, Anna, Guido Carillio, Agnese Montanino, et al.. (2016). Focus on Nintedanib in NSCLC and Other Tumors. Frontiers in Medicine. 3. 68–68. 12 indexed citations
14.
Cortinovis, Diego, Vanesa Gregorc, Maria Rita Migliorino, et al.. (2016). New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group. Critical Reviews in Oncology/Hematology. 109. 35–41. 14 indexed citations
15.
Crinò, Lucio, Paolo Bidoli, Angelo Delmonte, et al.. (2016). Italian cohort of nivolumab Expanded Access Programme (EAP): efficacy and safety data from a real-world population. Annals of Oncology. 27. iv3–iv3. 1 indexed citations
16.
Giordano, Pasqualina, Anna Manzo, Agnese Montanino, et al.. (2015). Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors. Critical Reviews in Oncology/Hematology. 97. 143–151. 29 indexed citations
17.
Capasso, Anna, Valentina Gambardella, Erika Martinelli, et al.. (2014). Cell Growth Inhibition of Her2 Positive Trastuzumab Resistant Gastric Cancer Cell Lines By Combined Inhibition of Pi3K/Akt/Mtor and Mapk. Annals of Oncology. 25. iv220–iv220. 2 indexed citations
18.
Morgillo, Floriana, Ferdinando Carlo Sasso, Carminia Maria Della Corte, et al.. (2013). Metformin in lung cancer: rationale for a combination therapy. Expert Opinion on Investigational Drugs. 22(11). 1401–1409. 25 indexed citations
19.
Morgillo, Floriana, Carminia Maria Della Corte, Giulia Martini, et al.. (2012). Role of the Hedgehog Pathway in Mediating Resistance to Anti-Egfr Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer. Annals of Oncology. 23. ix430–ix430. 1 indexed citations
20.
Ravaioli, Alessandra, Debora Canuti, Lorenzo Gianni, et al.. (1997). Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients. The Breast. 6(5). 275–280. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariano Siguero Breakdown of academic impact, for papers by Priscilla Cascetta Breakdown of academic impact, for papers by Kate Young Breakdown of academic impact, for papers by Monica Capozzi Breakdown of academic impact, for papers by Sakiko Otani Breakdown of academic impact, for papers by Tae‐You Kim Breakdown of academic impact, for papers by Yalei Zhang Breakdown of academic impact, for papers by Brigida Stanzione Breakdown of academic impact, for papers by Ryo Ko Breakdown of academic impact, for papers by Dario Nicolella
Rankless by CCL
2026